Literature DB >> 23995052

Parents' Perspectives About Factors Influencing Adherence to Pharmacotherapy for ADHD.

Rana Ahmed1, Jacqueline Borst2, Yong C Wei3, Parisa Aslani1.   

Abstract

OBJECTIVE: The aim of the present study was to explore factors influencing parents' decisions to adhere and persist with ADHD pharmacotherapy in children.
METHOD: Focus groups ( n = 3) were conducted with 16 parents recruited from metropolitan Sydney. Group discussions explored factors impacting on treatment initiation, continuation, and cessation. Focus groups were audio-recorded, transcribed verbatim, and thematically content analyzed.
RESULTS: Parents commenced and continued pharmacotherapy due to its positive impact on their child's behavior. Improvements in the child's academic performance and social interactions encouraged persistence with therapy. Parents elected to cease therapy after their children experienced side effects including appetite suppression, weight loss, and sleep disturbances. Concerns about long-term effects of ADHD medication use including potential for addiction and growth stunting, in addition to the stigma surrounding ADHD also contributed to parents ceasing treatment.
CONCLUSION: The findings highlight a need for the provision of accurate information about ADHD and its treatments to parents to empower their treatment decisions and promote adherence.

Entities:  

Keywords:  ADHD; adherence; attention-deficit/hyperactivity disorder; parents; pharmacotherapy

Mesh:

Substances:

Year:  2016        PMID: 23995052     DOI: 10.1177/1087054713499231

Source DB:  PubMed          Journal:  J Atten Disord        ISSN: 1087-0547            Impact factor:   3.256


  9 in total

1.  Predictors of Medication Continuity in Children With ADHD.

Authors:  William B Brinkman; Heidi Sucharew; Jessica Hartl Majcher; Jeffery N Epstein
Journal:  Pediatrics       Date:  2018-06       Impact factor: 7.124

2.  Medication-taking experiences in attention deficit hyperactivity disorder: a systematic review.

Authors:  Mohammed A Rashid; Sophie Lovick; Nadia R Llanwarne
Journal:  Fam Pract       Date:  2018-03-27       Impact factor: 2.267

3.  Insights from pre-treatment attrition & dropouts in an effectiveness trial of methylphenidate in children.

Authors:  Ruchita Shah; Susanta Padhy; Adarsh Kohli; Samita Sharma
Journal:  Indian J Med Res       Date:  2020-09       Impact factor: 2.375

4.  Eliciting preferences for continuing medication among adult patients and parents of children with attention-deficit hyperactivity disorder.

Authors:  Muhammad Umair Khan; Camila Balbontin; Michiel C J Bliemer; Parisa Aslani
Journal:  Health Expect       Date:  2022-03-10       Impact factor: 3.318

5.  Do parents of children with attention-deficit/hyperactivity disorder (ADHD) receive adequate information about the disorder and its treatments? A qualitative investigation.

Authors:  Rana Ahmed; Jacqueline M Borst; Cheng Wei Yong; Parisa Aslani
Journal:  Patient Prefer Adherence       Date:  2014-05-08       Impact factor: 2.711

6.  The design and user-testing of a question prompt list for attention-deficit/hyperactivity disorder.

Authors:  Rana Ahmed; David K Raynor; Kirsten J McCaffery; Parisa Aslani
Journal:  BMJ Open       Date:  2014-12-16       Impact factor: 2.692

7.  Odds of fussy eating are greater among children with obesity and anxiety.

Authors:  Sigrun Thorsteinsdottir; Anna S Olafsdottir; Berglind Brynjolfsdottir; Ragnar Bjarnason; Urdur Njardvik
Journal:  Obes Sci Pract       Date:  2021-08-07

8.  Predicting Use of Medications for Children with ADHD: The Contribution of Parent Social Cognitions.

Authors:  Ainsley Boudreau; Janet W T Mah
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2020-03-01

9.  The Effects of Extended-Release Stimulant Medication on Sleep in Children with ADHD.

Authors:  Penny Corkum; Esmot Ara Begum; Benjamin Rusak; Malgorzata Rajda; Sarah Shea; Marilyn MacPherson; Tracey Williams; Kathleen Spurr; Fiona Davidson
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2020-03-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.